Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	date of answer exactly: or between: and
creator	label
publisher	pref label
tabling member	label

Search

1194422

	human indexable
	published
	registered interest
	answer date	13/05/2020
	date	11/05/2020
	date tabled	11/05/2020
	ddp created	11/05/2020 19:37:19
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/05/2020 20:05:33 18/05/2020 16:15:13
	hansard heading	Zuhlke Engineering: Contact Tracing
	house id	1
	identifier	45256
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	18/05/2020 15:43:06
	question text	To ask the Secretary of State for Health and Social Care, what the value was of the contract awarded to Zuhlke Engineering for the development of the NHS covid-19 contact tracing app.
	session	2019/21
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2019/21 45256
	type	WrittenParliamentaryQuestion
	uin	45256
	version	1
	written parliamentary question type	Ordinary
	answer	answer date of answer 18/05/2020
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1580222

	human indexable
	published
	registered interest
	answer date	30/01/2023
	date	24/01/2023
	date tabled	24/01/2023
	ddp created	24/01/2023 20:00:56
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/01/2023 20:19:12 30/01/2023 17:25:25
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access: Life Sciences
	house id	1
	identifier	131295
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	30/01/2023 16:53:19
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Secretary of State for Business, Energy, and Industrial Strategy on the impact of the Voluntary Scheme for Branded Medicines Pricing Access on the life sciences sector.
	session	2022/23
	session number	3
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2022/23 131295
	type	WrittenParliamentaryQuestion
	uin	131295
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 30/01/2023
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1608018

	human indexable
	published
	registered interest
	answer date	30/03/2023
	date	27/03/2023
	date tabled	27/03/2023
	ddp created	27/03/2023 22:40:32
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	27/03/2023 23:08:20 30/03/2023 15:50:22
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access: Disclosure of Information
	house id	1
	identifier	174320
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	30/03/2023 15:18:28
	question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s ongoing VPAS pre-negotiation workshops, if he will publish the (a) minutes and (b) attendees of those workshops.
	session	2022/23
	session number	3
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2022/23 174320
	type	WrittenParliamentaryQuestion
	uin	174320
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 30/03/2023
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1608020

	human indexable
	published
	registered interest
	answer date	30/03/2023
	date	27/03/2023
	date tabled	27/03/2023
	ddp created	27/03/2023 22:40:37
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	27/03/2023 23:08:25 30/03/2023 15:50:20
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access: Disclosure of Information
	house id	1
	identifier	174321
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	30/03/2023 15:18:28
	question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s ongoing VPAS pre-negotiation workshops, whether he plans to make the outputs of those discussions publicly available.
	session	2022/23
	session number	3
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2022/23 174321
	type	WrittenParliamentaryQuestion
	uin	174321
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 30/03/2023
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1139442

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:34:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:43:37 22/07/2019 16:18:06
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	277757
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	22/07/2019 15:46:12
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 Voluntary Scheme for Branded Medicines Pricing and Access, how many opportunities there have been for pharmaceutical industry trade bodies to input into NHS England’s commercial framework; and what steps the Government is taking to secure the participation of industry trade bodies.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 277757
	type	WrittenParliamentaryQuestion
	uin	277757
	version	1
	written parliamentary question type	NamedDay
	answer	answer date of answer 22/07/2019
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1580218

	human indexable
	published
	registered interest
	answer date	30/01/2023
	date	24/01/2023
	date tabled	24/01/2023
	ddp created	24/01/2023 20:00:30
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	25/01/2023 14:45:36 30/01/2023 17:18:48
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	131294
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	30/01/2023 16:47:19
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes to the voluntary scheme for branded medicines pricing and access rebate rate on (a) investment in late-stage clinical trials and (b) patient access to new medicines.
	session	2022/23
	session number	3
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2022/23 131294
	type	WrittenParliamentaryQuestion
	uin	131294
	version	2
	written parliamentary question type	NamedDay
	answer	answer date of answer 30/01/2023
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1604911

	human indexable
	published
	registered interest
	answer date	20/03/2023
	date	16/03/2023
	date tabled	16/03/2023
	ddp created	16/03/2023 17:47:07
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/03/2023 18:10:54 23/03/2023 16:53:05
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	167135
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	23/03/2023 16:20:08
	question text	To ask the Secretary of State for Health and Social Care, if he will publish (a) the minutes from and (b) a list of attendees at the workshops his Department has been running ahead of negotiations on a new Voluntary Scheme for Branded Medicines Pricing and Access.
	session	2022/23
	session number	3
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2022/23 167135
	type	WrittenParliamentaryQuestion
	uin	167135
	version	1
	written parliamentary question type	Ordinary
	answer	answer date of answer 23/03/2023
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1604912

	human indexable
	published
	registered interest
	answer date	20/03/2023
	date	16/03/2023
	date tabled	16/03/2023
	ddp created	16/03/2023 17:47:11
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/03/2023 18:10:59 23/03/2023 16:52:38
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	167136
	legislature	25259 pref label House of Commons
	parliament number	58
	question first answered	23/03/2023 16:20:08
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to publish information about the outcomes from the workshops that his Department has been running ahead of negotiations on a new Voluntary Scheme for Branded Medicines Pricing and Access.
	session	2022/23
	session number	3
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2022/23 167136
	type	WrittenParliamentaryQuestion
	uin	167136
	version	1
	written parliamentary question type	Ordinary
	answer	answer date of answer 23/03/2023
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1020233

	human indexable
	published
	registered interest
	answer date	10/12/2018
	date	05/12/2018
	date tabled	05/12/2018
	ddp created	05/12/2018 21:41:34
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	05/12/2018 21:49:13 12/12/2018 15:26:03
	hansard heading	Vaccination
	house id	1
	identifier	199422
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	12/12/2018 14:55:49
	question text	To ask the Secretary of State for Health and Social Care, if he will place in the Library (a) all instances where the Joint Committee on Vaccination and Immunisation has recommended a change to a vaccination programme that would be likely to result in an increase in disease incidence, (b) whether those recommendations were accepted by Ministers and (c) the subsequent changes in disease incidence following those decisions.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 199422
	type	WrittenParliamentaryQuestion
	uin	199422
	version	1
	written parliamentary question type	Ordinary
	answer	answer date of answer 12/12/2018
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner

1055992

	human indexable
	published
	registered interest
	answer date	08/02/2019
	date	06/02/2019
	date tabled	06/02/2019
	ddp created	06/02/2019 18:03:35
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	06/02/2019 18:22:50 14/02/2019 17:53:06
	hansard heading	Vaccination
	house id	1
	identifier	217595
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	14/02/2019 17:20:40
	question text	To ask the Secretary of State for Health and Social Care, with reference to his policy paper Tackling antimicrobial resistance 2019 to 2024: the UK's 5-year national action plan, if he will amend the code of practice for the Joint Committee on Vaccination and Immunisation to require that Committee to assess the effect on the level of anti-microbial resistance of (a) a new, (b) major changes to and (c) the discontinuation of an immunisation programme.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 217595
	type	WrittenParliamentaryQuestion
	uin	217595
	version	1
	written parliamentary question type	Ordinary
	answer	answer date of answer 14/02/2019
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259 pref label House of Commons
	tabling member	4382 label Biography information for Daniel Zeichner